Phentermine

Definition

Phentermine is an FDA-approved anorectic (appetite-suppressing) medication indicated as a short-term adjunct to diet and exercise for weight reduction in patients with a BMI of 30 or higher, or 27 or higher with weight-related conditions. It stimulates the release of norepinephrine in the hypothalamus, reducing appetite. It is typically prescribed for up to 12 weeks, though some clinicians prescribe it longer. Phentermine/topiramate extended-release (Qsymia) is a combination formulation approved for longer-term use. Unlike GLP-1 medications, phentermine does not address the metabolic root causes of weight retention — it suppresses appetite through stimulant mechanisms and is not appropriate for patients with cardiovascular disease or uncontrolled hypertension.

Frequently Asked Question

How does phentermine differ from GLP-1 medications for weight loss?

GLP-1 medications work on the brain's hormonal satiety signaling system — they restore appropriate hunger regulation by mimicking a gut hormone, reduce food noise at the neurological level, improve insulin sensitivity, and produce metabolic benefits in blood pressure, blood sugar, and cardiovascular markers. Phentermine works as a stimulant — it triggers norepinephrine release to blunt appetite through a central nervous system mechanism, without addressing the metabolic or hormonal drivers of weight gain. GLP-1 therapy treats the biology beneath the weight problem; phentermine manages the symptom of hunger without changing what is driving it.

Is phentermine safe for women in perimenopause or menopause?

Phentermine is contraindicated in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, and several other conditions — all of which are more prevalent in midlife women. It can also elevate blood pressure and heart rate and is not appropriate for long-term use. Women in this life stage require careful clinical evaluation before phentermine is considered appropriate.

Why is phentermine typically only approved for short-term use?

Phentermine is classified as a Schedule IV controlled substance and carries risks of dependence, cardiovascular effects, and tolerance. It was approved decades ago under different regulatory standards than today's weight loss medications. Newer agents like GLP-1 receptor agonists have demonstrated safety and efficacy for long-term, ongoing use with a more favorable metabolic and cardiovascular risk profile.

Why Phentermine Matters

Phentermine is often the first weight loss medication name patients encounter — through a friend, an online ad, or a previous prescription. Many arrive at SPOKEmed asking whether phentermine is an option or how it compares to GLP-1 therapy. Understanding the clinical differences — mechanism, duration of use, appropriate patient profile, and what it does and does not address metabolically — helps patients make informed decisions about why SPOKEmed's approach centers on GLP-1 therapy rather than stimulant-based suppression.

How Spokmed Company Uses It

Phentermine is not part of SPOKEmed's clinical toolkit. Michelle Middleton, PA-C's approach to weight management addresses the underlying metabolic and hormonal drivers of weight retention — insulin resistance, cortisol dysregulation, leptin resistance, hormonal shifts of perimenopause — rather than suppressing appetite through stimulant mechanisms that do not address root causes. GLP-1 medications and integrative metabolic protocols are SPOKEmed's evidence-based alternatives for patients who have been offered phentermine elsewhere and want a more comprehensive approach.

Phentermine

Definition

Frequently Asked Question

How does phentermine differ from GLP-1 medications for weight loss?

Is phentermine safe for women in perimenopause or menopause?

Why is phentermine typically only approved for short-term use?

Why Phentermine Matters

How Spokmed Company Uses It

Related Services

Related Terms

"Phentermine" Appears in These Categories